TNK2 and breast carcinoma: Migration was slower in cells transfected with targeting siRNA (S1, S3) than control nontargeting siRNA (N), demonstrating that silencing of TNK2 inhibits human breast cancer cell migration (Figure 4a for MDA-MB-231 cells; Additional file 1A for MCF-7 cells).